Additional references cited in the text for "CORONARY DISEASE: Intervention in coronary artery disease"

Stephan Windecker, Bernhard Meier

Heart 2000;83:481

1 Waller BF. Coronary luminal shape and the arc of disease-free wall: morphologic observations and clinical relevance. J Am Coll Cardiol 1985;6:1100—1.

2 Sanborn TA, Faxon DP, Haudenschild C, et al. The mechanism of transluminal angioplasty: evidence for formation of aneurysms in experimental atherosclerosis. Circulation 1983;68:1136—40.

3 Faxon DP, Sanborn TA, Haudenschild CC. Mechanism of angioplasty and its relation to restenosis. Am J Cardiol 1987;60:5B--9B.

4 Honye J, Mahon DJ, Jain A, et al. Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation 1992;85:1012—25.

5 Ellis SG, Cowley MJ, Whitlow PL, et al. Prospective case-control comparison of percutaneous transluminal coronary revascularization in patients with multivessel disease treated in 1986—1987 versus 1991: improved in-hospital and 12-month results. Multivessel Angioplasty Prognosis Study (MAPS) Group. J Am Coll Cardiol 1995;25:1137—42.

6 Myler R, Shaw R, Sterzer S, et al. Lesion morphology and coronary angioplasty: current experience and analysis. J Am Coll Cardiol 1992;19:1641—52.

7 Meier B. Balloon angioplasty. In: Topol EJ, ed. Comprehensive cardiovascular medicine. Philadelphia: Lippincott-Raven, 1998:2251—84.

8 Landau C, Lange RA, Hillis LD. Percutaneous transluminal coronary angioplasty. N Engl J Med 1994;330:981—93.

9 Ellis SG, Roubin GS, King SB, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988;77:372—9.

10 Simpfendorfer C, Belardi J, Bellamy G, et al. Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty. Am J Cardiol 1987;59:267—9.

11 Lincoff AM, Popma JJ, Ellis SG, et al. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992;19:926—35.

12 Lincoff AM, Topol EJ. Abrupt vessel closure. In: Topol EJ, ed. Tectbook of interventional cardiology, 3rd edn. Philadelphia: WB Saunders, 1999:163—87.

13 Serruys P, Azar A, Sigwart U, et al. Long-term follow-up of stent-like (<30% diameter stenosis post) angioplasty: a case for provisional stenting. J Am Coll Cardiol 1996;27(suppl):15A.

14 Serruys PW, di Mario C, Piek J, et al. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE study (Doppler endpoints balloon angioplasty trial Europe). Circulation 1997;96:3369—77.

15 Rodriguez A, Ayala F, Bernardi V, et al. Optimal coronary balloon angioplasty with provisional stenting versus primary stent (OCBAS): immediate and long-term follow-up results. J Am Coll Cardiol 1998;32:1351—7.

16 Eeckhout E, Kappenberger L, Goy JL. Stents for intracoronary placement: current status and future directions. J Am Coll Cardiol 1996;27:757—65.

17 Ruygrok PN, Serruys PW. Intracoronary stenting. From concept to custom. Circulation 1996;94:882—90.

18 Holmes DR Jr, Hirshfeld J Jr, Faxon D, et al. ACC expert consensus document on coronary artery stents. Document of the American College of Cardiology. J Am Coll Cardiol 1998;32:1471—82.

19 Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998;352:673—81.

20 Versaci F, Gaspardone A, Tomai F, et al. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 1997;336:817—22.

21 Erbel R, Haude M, Hopp HW, et al. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis stent study group. N Engl J Med 1998;339:1672—8.

22 Savage MP, Douglas JS Jr, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous vein de novo trial investigators. N Engl J Med 1997;337:740—7.

23 Suryapranata H, van’t Hof AWJ, Hoorntje JCA, et al. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998;97:2502—5.

24 Sirnes PA, Golf S, Myreng Y, et al. Stenting in chronic coronary occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996;28:1444—51.

25 Antoniucci D, Santoro GM, Bolognese L, et al. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence randomized elective stenting in acute coronary occlusions (FRESCO) trial. J Am Coll Cardiol 1998;31:1234—9.

26 Buller CE, Dzavik V, Carere RG, et al. Primary stenting versus balloon angioplasty in occluded coronary arteries. The total occlusion study of Canada (TOSCA). Circulation 1999;100:236—42.

27 Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676—88.

28 Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084—9.

29 Bauters C, Banos J-L, Van Belle E, et al. Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. Circulation 1998;97:318—21.

30 Topol EJ. Caveats about elective coronary stenting. N Engl J Med 1994;331:539—41.

31 Adelman AG, Cohen EA, Kimball BP, et al. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med 1993;329:228—33.

32 Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993;329:221—7.

33 Baim DS, Cutlip DE, Sharma SK, et al. Final results of the balloon vs optimal atherectomy trial (BOAT). Circulation 1998;97:322—31.

34 Holmes DR Jr, Topol EJ, Califf RM, et al. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II investigators. Circulation 1995;91:1966—74.

35 Friedman HZ, Elliott MA, Gottlieb GJ, et al. Mechanical rotary atherectomy: the effects of microparticle embolization on myocardial blood flow and function. J Interv Cardiol 1989;2:77—83.

36 Zotz R, Erbel R, Philip A, et al. High-speed rotational angioplasty-induced echo contrast in vivo and in vitro optical analysis. Cathet Cardiovasc Diagn 1992;26:98—109.

37 Stertzer SH, Pomerantsev EV, Fitzgerald PJ, et al. Effect of technique modification on immediate results of high speed rotational atherectomy in 710 procedures on 656 patients. Cathet Cardiovasc Diagn 1995;36:304—10.

38 Reisman M, Harms V. Guidewire bias: potential source of complications with rotational atherectomy. Cathet Cardiovasc Diagn 1996;37:64—8.

39 Grundfest WS, Segalowitz J, Laudesnlager J, et al. The physical and biological basis for laser angioplasty. In: Litvack F, ed. Coronary laser angioplasty: Blackwell Scientific Publications, 1992:1—12.

40 Mintz GS, Kovach JA, Javier SP, et al. Mechanisms of lumen enlargement after excimer laser coronary angioplasty. An intravascular ultrasound study. Circulation 1995;92:3408—14.

41 van Leeuwen TG, Borst C. Fundamental laser-tissue interactions. Seminars in Interventional Cardiology 1996;1:121—8.

42 van Leeuwen TG, Meertens JH, Velema E, et al. Intraluminal vapor bubble induced by excimer laser pulse causes microsecond arterial dilation and invagination leading to extensive wall damage in the rabbit. Circulation 1993;87:1258—63.

43 van Leeuwen TG, van Erven L, Meertens JH, et al. Origin of arterial wall dissections induced by pulsed excimer and mid-infrared laser ablation in the pig. J Am Coll Cardiol 1992;19:1610—8.

44 Deckelbaum LI. Cardiovascular applications of laser technology. Lasers Surg Med 1994;15:315—41.

45 Deckelbaum LI, Natarajan MK, Bittl JA, et al. Effect of intracoronary saline infusion on dissection during excimer laser coronary angioplasty: a randomized trial. The percutaneous excimer laser coronary angioplasty (PELCA) investigators. J Am Coll Cardiol 1995;26:1264—9.

46 Topaz O. Holmium laser angioplasty. Seminars in Interventional Cardiology 1996;1:149—61.

47 Hamburger JN, Gijsbers GH, Ozaki Y, et al. Recanalization of chronic total coronary occlusions using a laser guide wire: a pilot study. J Am Coll Cardiol 1997;30:649—56.

48 Hirsh J, Fuster V. Guide to anticoagulant therapy. Part 2: oral anticoagulants. Circulation 1994;89:1469—80.

49 Narins CR, Hillegass Jr WB, Nelson CL, et al. Relation between activated clotting time during angioplasty and abrupt closure. Circulation 1996;93:667—71.

50 Boccara A, Benamer H, Juliard JM, et al. A randomized trial of a fixed high dose vs a weight-adjusted low dose of intravenous heparin during coronary angioplasty. Eur Heart J 1997;18:631—5.

51 Garachemani A, Meier B. Heparin for coronary angioplasty: high dose, low dose, or no dose? Heart 1998;80:3—4.

52 Vainer J, Fleisch M, Gunnes P, et al. Low dose heparin for routine coronary angioplasty and stenting. Am J Cardiol 1996;78:964—6.

53 Friedman HZ, Cragg DR, Glazier SM, et al. Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty. J Am Coll Cardiol 1994;24:1214—9.

54 Weitz JI. Low-molecular-weight heparins N Engl J Med 1997;337:688—98.

55 Preisack MB, Bonan R, Meisner C, et al. Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty. A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial). Eur Heart J 1998;19:1232—8.

56 Serruys PW, Herrman JP, Simon R, et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N Engl J Med 1995;333:757—63.

57 The GUSTO IIb Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The global use of strategies to open occluded coronary arteries in acute coronary syndromes (GUSTO IIb) angioplasty substudy investigators. N Engl J Med 1997;336:1621—8.

58 Bittl JA, Strony J, Brinker JA, et al. Treatment with bivalirudin (hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med 1995;333:764—9.

59 Urban P, Macaya C, Rupprecht HJ, et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). Circulation 1998;98:2126—32.

60 Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation 1998;98:1597—603.

61 Schwartz L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988;318:1714—9.

62 Lembo NJ, Black AJR, Roubin GS, et al. Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty. Am J Cardiol 1990;65:422—6.

63 Quinn MJ, Fitzgerald DJ. Ticlopidine and clopidogrel. Circulation 1999;100:1667—72.

64 Topol EJ. Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence. Circulation 1998;97:211—8.

65 Schömig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084—9.

66 Moussa I, Oetgen M, Roubin G, et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 1999;99:2364—6.

67 The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC investigation. N Engl J Med 1994;330:956—61.

68 The CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 1997;349:1429—35.

69 The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT investigators. Evaluation of platelet IIb/IIIa inhibitor for stenting. Lancet 1998;352:87—92.

70 Brener SJ, Barr LA, Burchenal JE, et al. Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. RAPPORT investigators. ReoPro and primary PTCA organization and randomized trial. Am J Cardiol 1999;84:728—30, A8.

71 The IMPACT-II Investigators. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to minimise platelet aggregation and coronary thrombosis-II. Lancet 1997;349:1422—8.

72 The RESTORE Investigators. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE investigators. Randomized efficacy study of tirofiban for outcomes and restenosis. Circulation 1997;96:1445—53.

73 Topol EJ, Ferguson JJ, Weisman HF, et al. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC investigator group. Evaluation of platelet IIb/IIIa inhibition for prevention of ischemic complication [[see comments]]. JAMA 1997;278:479—84.

74 Windecker S, Meyer BJ, Bonzel T, et al. Interventional cardiology in Europe 1995. Eur Heart J 1999;20:484—95.

75 Hannan EL, Racz M, Ryan TJ, et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA 1997;277:892—8.

76 Jollis JG, Peterson ED, DeLong ER, et al. The relation between the volume of coronary angioplasty procedures at hospitals treating medicare beneficiaries and short-term mortality. N Engl J Med 1994;331:1625—9.

77 Jollis JG, Peterson ED, Nelson CL, et al. Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients [[see comments]]. Circulation 1997;95:2485—91.

78 Ellis SG, Weintraub W, Holmes D, et al. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes [[see comments]]. Circulation 1997;95:2479—84.

79 Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus revascularization treatment investigators. N Engl J Med 1999;341:70—6.

80 Goy JJ, Eeckhout E, Moret C, et al. Five-year outcome in patients with isolated proximal left anterior descending coronary artery stenosis treated by angioplasty or left internal mammary artery grafting. A prospective trial. Circulation 1999;99:3255—9.

81 Hamm CW, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 1994;331:1037—43.

82 King SB, III, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994;331:1044—50.

83 CABRI Trial Participants. First-year results of CABRI (coronary angioplasty versus bypass revascularisation investigation). Lancet 1995;346:1179—84.

84 Rodriguez A, Mele E, Peyregne E, et al. Three-year follow-up of the Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI). J Am Coll Cardiol 1996;27:1178—84.

85 Henderson RA, Pocock SJ, Sharp SJ, et al. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention treatment of angina. Lancet 1998;352:1419—25.